TCM
Tang Capital Management Portfolio holdings
AUM
$1.98B
1-Year Return
21.62%
This Quarter Return
-3.24%
1 Year Return
+21.62%
3 Year Return
+290.69%
5 Year Return
+284.46%
10 Year Return
+928.34%
AUM
$709M
AUM Growth
+$29.4M
(+4.3%)
Cap. Flow
+$74.6M
Cap. Flow
% of AUM
10.53%
Top 10 Holdings %
Top 10 Hldgs %
39.27%
Holding
116
New
17
Increased
23
Reduced
16
Closed
10
Top Buys
| 1 |
EQRX
EQRx, Inc. Common Stock
EQRX
|
$22.4M |
| 2 |
Intellia Therapeutics
NTLA
|
$12.6M |
| 3 |
AVDL
Avadel Pharmaceuticals
AVDL
|
$10.3M |
| 4 |
KalVista Pharmaceuticals
KALV
|
$7.6M |
| 5 |
Tarsus Pharmaceuticals
TARS
|
$6.42M |
Top Sells
| 1 |
BLUE
bluebird bio
BLUE
|
$9.42M |
| 2 |
Capital One
COF
|
$8.75M |
| 3 |
BioCryst Pharmaceuticals
BCRX
|
$4.6M |
| 4 |
Pyxis Oncology
PYXS
|
$4.58M |
| 5 |
Phathom Pharmaceuticals
PHAT
|
$3.58M |
Sector Composition
| 1 | Healthcare | 94.04% |
| 2 | Financials | 5.11% |
| 3 | Real Estate | 0.78% |
| 4 | Consumer Discretionary | 0.07% |
| 5 | Utilities | 0% |
